Atai Therapeutics US12606525B2 Patent Grant
Summary
USPTO granted patent US12606525B2 to Atai Therapeutics, Inc. covering dimethyltryptamine analogues as nitric oxide delivery drugs, specifically compounds of Formula (I) or (II) and pharmaceutical compositions comprising those compounds. The patent was granted on April 21, 2026, with application number 18657306 and 34 claims.
What changed
USPTO granted patent US12606525B2 to Atai Therapeutics, Inc. for dimethyltryptamine analogues as nitric oxide delivery drugs, classified under CPC C07D 209/16. The patent covers compounds of Formula (I) or (II) and pharmaceutical compositions comprising those compounds.
Patent holders and pharmaceutical companies developing nitric oxide-related therapeutics should be aware that this patent may encumber freedom-to-operate in this chemical space. Competitors researching DMT analogues for therapeutic applications should conduct freedom-to-operate analyses and consider potential licensing arrangements.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Dimethyltryptamine analogues as nitric oxide delivery drugs
Grant US12606525B2 Kind: B2 Apr 21, 2026
Assignee
Atai Therapeutics, Inc.
Inventors
Robert B. Perni, Glenn Short, Tanweer A. Khan
Abstract
Provided herein are compounds of Formula (I), (II), or a pharmaceutically acceptable salt thereof. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I), (II), or pharmaceutically acceptable salt thereof, and methods of using a compound of Formula (I), (II), or a pharmaceutically acceptable salt thereof.
CPC Classifications
C07D 209/16
Filing Date
2024-05-07
Application No.
18657306
Claims
34
Mentioned entities
Parties
Related changes
Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.